- 1) Kirach, K. S., Editorial: suprising places of estrogenic activity. Endocrinology, 132, 2277–2278 (1993).
- 2) Stone, R., Environmental estrogens stir debate. Science, 265, 308–310 (1994).
- 3) Ben-Jonathan, N., and Steinmetz, R., Xenoestrogens: the emerging story of bisphenol A. Trends Endocrinol. Metab., 9, 124–128 (1998).
- 4) Lazear, N. R., Polycarbonate: high-performance resin. Adv. Mater. Process., 417, 43–45 (1994).
- 5) Howdeshell, K. L., Hotchkiss, A. K., Thayer, K. A., Vandenbergh, J. G., and vom Saal, F. S., Exposure to bisphenol A advances puberty. Nature, 401, 763–764 (1999).
- 6) Ikezuki, Y., Tsutsumi, O., Takai, Y., Kamei, Y., and Taketani, Y., Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod., 17, 2839–2841 (2002).
- 7) Sakamoto, H., Yokota, H., Kibe, R., Sayama, Y., and Yuasa, A., Excretion of bisphenol A-glucuronide into the small intestine and deconjugation in the cecum of the rat. Biochim. Biophys. Acta, 1573, 171–176 (2002).
- 8) Pottenger, L. H., Domoradzki, J. Y., Markham, D. A., Hansen, S. C., Cagen, S. Z., and Waechter, Jr., J. M., The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci., 54, 3–18 (2000).
- 9) Matthew, J. B., Twomey, K., and Zacharewski, T. R., In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol., 14, 149–157 (2001).
- 10) Asahara, T., Nomoto, K., Watanuki, M., and Yokokura, T., Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrobial. Agents Chemother., 45, 1751–1760 (2001).
- 11) Asahara, T., Shimizu, K., Nomoto, K., Hamabata, T., Ozawa, A., and Takeda, Y., Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun., 72, 2240–2247 (2004).
- 12) Matsuzaki, T., Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol., 41, 133–140 (1998).
- 13) Matsuzaki, T., and Chin, J., Modulating immune responses with probiotic bacteria. Immunol. Cell Biol., 78, 67–73 (2000).
- 14) Yasui, H., Shida, K., Matsuzaki, T., and Yokokura, T., Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek, 76, 383–389 (1999).
- 15) Reddy, B., and Riverson, A., Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res., 53, 3914–3918 (1993).
- 16) Takagi, A., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., and Yokokura, T., Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice. Med. Microbiol. Immunol., 188, 111–116 (1999).
- 17) Ito, M., Sawada, H., Ohishi, K., Yoshida, Y., Yokoi, W., Watanabe, T., and Yokokura, T., Suppressive effects of bifidobacteria on lipid peroxidation in the colonic mucosa of iron-overloaded mice. J. Dairy Sci., 84, 1583–1589 (2001).
- 18) Ito, M., Ohishi, K., Yoshida, Y., Yokoi, W., and Sawada, H., Antioxidative effects of lactic acid bacteria on the colonic mucosa of iron-overloaded mice. J. Agric. Food Chem., 51, 4456–4460 (2003).
- 19) Bolognani, F., Rumney, C. J., and Rowland, I. R., Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem. Toxicol., 35, 535–545 (1997).
- 20) Morotomi, M., and Mutai, M., In vitro binding of potent mutagenic pyrolyzates to intestinal bacteria. J. Natl. Cancer Inst., 77, 195–201 (1986).
- 21) Hayatsu, H., and Hayatsu, T., Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett., 73, 173–179 (1993).
- 22) Brotons, J. A., Olea-Serrano, M. F., Villalobos, M., Pedraza, V., and Olea, N., Xenoestrogens released from lacquer coatings in food cans. Environ. Health Perspect., 103, 608–612 (1995).
- 23) Inoue, H., Yokota, H., Makino, T., Yuasa, A., and Kato, S., Bisphenol A glucuronide, a major metabolite in rat bile after liver perfusion. Drug Metab. Dispos., 29, 1084–1087 (2001).
- 24) Olivares, M., Diaz-Ropero, M. A., Gomez, N., Lara-Villoslada, F., Sierra, S., Maldonado, J. A., Martin, R., Lopez-Huertas, E. J., Rodriguez, M., and Xaus, J., Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int. J. Food Microbiol., 107, 104–111 (2006).
- 25) Endo, Y., Kimura, N., Ikeda, I., Fujimoto, K., and Kimoto, H., Adsorption of bisphenol A by lactic acid bacteria, Lactococcus, strains. Appl. Microbiol. Biotechnol., 74, 202–207 (2007).
- 26) Haskard, C., Binnion, C., and Ahokas, J., Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem. Biol. Interact., 128, 39–49 (2000).
Bioscience, Biotechnology, and Biochemistry
Volume 72, 2008 - Issue 6